Cover Image
市場調查報告書

美國的人工心臟瓣膜市場:2016年 (2022年前的預測)

US Market for Heart Valve Devices - 2016 (Forecasted to 2022)

出版商 iData Research Inc. 商品編碼 146785
出版日期 內容資訊 英文 134 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的人工心臟瓣膜市場:2016年 (2022年前的預測) US Market for Heart Valve Devices - 2016 (Forecasted to 2022)
出版日期: 2015年09月01日 內容資訊: 英文 134 Pages
簡介

美國的人工心臟瓣膜市場在近年來由於三尖瓣的修復手術的數量增加,在2015年將達到著1萬件以上。過去一直認為「治療主動脈或二尖瓣就能治好三尖瓣逆流」,三尖瓣的手術一直未能盛行,但由於心臟醫生開始意識到三尖瓣逆流不治療的危險性,治療手術在近年終於開始增加。但因為三尖瓣逆流致死的死亡率低,三尖瓣移植手術目前仍然不高。另一方面,美國大部分經導管心臟瓣膜手術目前仍由TAVI (經導管主動脈瓣移植)設備所佔。FDA (美國食品藥物管理局) 積極核凖認證的動向,也是促使TAVI設備利用增加的一個原因。

本報告提供美國的心血管手術設備 (人工心臟瓣膜) 市場相關分析,彙整各產品市場概要和競爭趨勢等相關資訊。

目錄

圖表一覽

摘要整理

分析方法

  • 分析範圍
  • IDATA的9級分析方法

生物學心臟瓣膜市場

  • 簡介
  • 治療數量
    • 心臟瓣膜的類別
    • 設備的類別
    • 組織的類別
  • 市場概要
  • 市場分析與預測
    • 整體市場規模
    • 設備類別市場
    • 附支架心臟瓣膜的市場
    • 無支架心臟瓣膜的市場
    • 無縫合心臟瓣膜的市場
    • 不同種類組織的市場
    • 異質骨移植的市場
    • 異體移植片的市場
  • 推動及阻礙市場要素
  • 競爭分析

機械瓣膜市場

  • 簡介
  • 治療數量
    • 心臟瓣膜的類別
  • 市場概要
  • 市場分析與預測
    • 整體市場規模
    • 無導管機械瓣膜的市場
    • 附導管機械瓣膜的市場
  • 推動及阻礙市場要素
  • 競爭分析

瓣環成形術設備市場

  • 簡介
  • 治療數量
    • 心臟瓣膜的類別
    • 組織的類別
  • 市場概要
  • 市場分析與預測
    • 整體市場規模
    • 環設備市場
    • 帶設備市場
  • 推動及阻礙市場要素
  • 競爭分析
    • 大企業
    • 未來性潛力企業

經導管心臟瓣膜修復設備

  • 簡介
  • 治療數量
  • 市場分析與預測
  • 推動及阻礙市場要素
  • 競爭分析
    • 大企業
    • 具有未來性潛力的企業

經導管心臟瓣膜置換市場

  • 簡介
  • 治療數量
  • 市場分析與預測
    • 經導管主動脈瓣置換市場
    • 新市場
    • 經導管二尖瓣置換市場
    • 經導管肺動脈瓣置換市場
  • 推動及阻礙市場要素
  • 競爭分析
    • 大企業
    • 具有未來性潛力的企業

簡稱一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_USHV16_RPT

In the past, it was assumed that correcting aortic or mitral valve disease would reduce tricuspid regurgitation. This assumption has historically kept the volume of tricuspid repair and replacement procedures relatively low. While the volume of tricuspid replacement procedures has remained low in recent years, the volume of tricuspid repair procedures has increased strongly, reaching over 10,000 procedures in 2015. The increase in tricuspid repair procedures has been pushed by a growing awareness among cardiologists of the hazards of leaving severe tricuspid regurgitation untreated. The volume of tricuspid replacement procedures has remained low due to the lower mortality rates associated with tricuspid repair relative to replacement.

The U.S. market for transcatheter heart valve devices comprises transcatheter repair and implantation devices. Though the markets for transcatheter repair and implantation devices have both experienced rapid growth in recent years, as of 2015, the majority of the U.S. market for transcatheter heart valve devices is represented by transcatheter aortic valve implantation (TAVI) devices. Strong growth in the U.S. market for TAVI devices has been set in motion by FDA approvals expanding the indication for use of these devices.

In June 2015, the FDA approved Edwards Lifesciences' SAPIEN 3® Transcatheter Heart Valve (THV) and Medtronic's CoreValve Evolut R® System for treating patients who are at high risk for open-heart surgery. The wider range of patients able to receive treatment with TAVI devices has driven double-digit growth in unit sales in recent years. Medtronic's entry into the U.S. market for TAVI devices has also helped to power growth in the value of the market. Since receiving approval from the FDA for the CoreValve® in early 2014, Medtronic has rapidly gained share in the U.S. market for TAVI devices. Despite the growing popularity of the CoreValve®, Edwards' SAPIEN® valve continues to hold the largest share of the U.S. market for TAVI devices.

This Report includes Segments On:

  • Tissue Heart Valves
  • Mechanical Heart Valves
  • Annuloplasty Repair Device Market
  • Transcatheter Heart Valve Repair Devices
  • Transcatheter Heart Valve Implantations

This 134 Page Report Includes:

  • In-depth, Professionally Researched Data That Has Been Formatted and Analyzed to Gain Actionable Insights as Quickly as Possible
  • Executive Summary
  • Trend Analysis by Segment
  • Market Value Forecasts until 2022 and History Back to 2012
  • Market Drivers and Limiters
  • Detailed Competitive Analysis for Each Market and Segment

In the past, it was assumed that correcting aortic or mitral valve disease would reduce tricuspid regurgitation. This assumption has historically kept the volume of tricuspid repair and replacement procedures relatively low. While the volume of tricuspid replacement procedures has remained low in recent years, the volume of tricuspid repair procedures has increased strongly. The increase in tricuspid repair procedures has been pushed by a growing awareness among cardiologists of the hazards of leaving severe tricuspid regurgitation untreated. The volume of tricuspid replacement procedures has remained low due to the lower mortality rates associated with tricuspid repair relative to replacement.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 SURGICAL HEART VALVE REPAIR & REPLACEMENT DEVICES MARKET
  • 1.2 TRANSCATHETER HEART VALVE DEVICES MARKET

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

TISSUE HEART VALVE MARKET

  • 3.1 INTRODUCTION
  • 3.2 PROCEDURE NUMBERS
    • 3.2.1 Tissue Valve Replacement Procedures by Valve Type
    • 3.2.2 Tissue Valve Replacement Procedures by Device Type
    • 3.2.3 Tissue Valve Replacement Procedures by Tissue Type
      • 3.3 MARKET OVERVIEW
      • 3.4 MARKET ANALYSIS AND FORECAST
    • 3.4.1 Total Tissue Heart Valve Market
    • 3.4.2 Tissue Heart Valve Market by Device Type
    • 3.4.2.1 Stented Tissue Heart Valve Market
    • 3.4.2.2 Stentless Tissue Heart Valve Market
    • 3.4.2.3 Sutureless Tissue Heart Valve Market
    • 3.4.3 Tissue Heart Valve Market by Tissue Type
    • 3.4.3.1 Xenograft Tissue Heart Valve Market
    • 3.4.3.2 Allograft Tissue Heart Valve Market
  • 3.5 DRIVERS AND LIMITERS
    • 3.5.1 Market Drivers
    • 3.5.2 Market Limiters
  • 3.6 COMPETITIVE ANALYSIS

MECHANICAL HEART VALVE MARKET

  • 4.1 INTRODUCTION
  • 4.2 PROCEDURES NUMBERS
    • 4.2.1 Mechanical Valve Replacement Procedures by Valve Type
    • 4.2.2 Mechanical Valve Replacement Procedures by Valve Type
  • 4.3 MARKET OVERVIEW
  • 4.4 MARKET ANALYSIS AND FORECAST
    • 4.4.1 Total Mechanical Heart Valve Market
    • 4.4.2 Mechanical Valve w/out Conduit Market
    • 4.4.3 Mechanical Valve w/ Conduit Market
  • 4.5 DRIVERS AND LIMITERS
    • 4.5.1 Market Drivers
    • 4.5.2 Market Limiters
  • 4.6 COMPETITIVE ANALYSIS

ANNULOPLASTY REPAIR DEVICE MARKET

  • 5.1 INTRODUCTION
  • 5.2 PROCEDURE NUMBERS
    • 5.2.1 Annuloplasty Repair Procedures by Valve Type
    • 5.2.2 Annuloplasty Repair Procedures by Device Type
  • 5.3 MARKET OVERVIEW
  • 5.4 MARKET ANALYSIS AND FORECAST
    • 5.4.1 Total Annuloplasty Repair Device Market
    • 5.4.2 Ring Device Market
    • 5.4.3 Band Device Market
  • 5.5 DRIVERS AND LIMITERS
    • 5.5.1 Market Drivers
    • 5.5.2 Market Limiters
  • 5.6 COMPETITIVE ANALYSIS
    • 5.6.1 Leading Competitors
    • 5.6.2 Potential Competitors

TRANSCATHETER HEART VALVE REPAIR DEVICE MARKET

  • 6.1 INTRODUCTION
  • 6.2 PROCEDURE NUMBERS
    • 6.2.1 Transcatheter Heart Valve Repair Procedures
  • 6.3 MARKET ANALYSIS AND FORECAST
    • 6.3.1 Transcatheter Heart Valve Repair Device Market
  • 6.4 DRIVERS AND LIMITERS
    • 6.4.1 Market Drivers
    • 6.4.2 Market Limiters
  • 6.5 COMPETITIVE ANALYSIS
    • 6.5.1 Leading Competitors
    • 6.5.2 Potential Competitors

TRANSCATHETER HEART VALVE IMPLANTATION MARKET

  • 7.1 INTRODUCTION
  • 7.2 PROCEDURE NUMBERS
    • 7.2.1 Transcatheter Heart Valve Implantation Procedures
  • 7.3 MARKET ANALYSIS AND FORECAST
    • 7.3.1 Transcatheter Aortic Valve Implantation Market
    • 7.3.2 Emerging Markets
    • 7.3.2.1 Transcatheter Mitral Valve Implantation Market
    • 7.3.2.2 Transcatheter Pulmonary Valve Implantation Market
  • 7.4 DRIVERS AND LIMITERS
    • 7.4.1 Market Drivers
    • 7.4.2 Market Limiters
  • 7.5 COMPETITIVE ANALYSIS
    • 7.5.1 Leading Competitors
    • 7.5.2 Potential Competitors
      • 7.5.2.1 Transcatheter Aortic Valve Implantation Market
      • 7.5.2.2 Transcatheter Mitral Valve Implantation Market
      • 7.5.2.3 Transcatheter Pulmonary Valve Implantation Market

ABBREVIATIONS 115

Back to Top